AstraZeneca will supply 200 doses of the coronavirus vaccine candidate AZD1222 to the U.S. Army under a $286.9M firm-fixed-price contract.
AstraZeneca has secured a $486M contract from the departments of Health and Human Services and Defense to further develop and test…
AstraZeneca and the Department of Health and Human Services have signed a potential $1.2B public-private partnership agreement to further develop a recombinant adenovirus vaccine…
Health Agencies, Biopharmaceutical Firms Form Partnership to Accelerate COVID-19 Vaccine Development
The National Institutes of Health and three other U.S. health agencies have teamed up with the Foundation for the NIH,…
